Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/01/2009 | CA2258561C Glyceraldehyde-3-phosphate dehydrogenase and nuclear restoration of cytoplasmic male sterility |
09/01/2009 | CA2213343C Chimeric adenoviral fiber protein and methods of using same |
09/01/2009 | CA2163454C Regulation of plant growth |
09/01/2009 | CA2087614C Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
08/29/2009 | CA2621155A1 Stem cell expression cassettes |
08/27/2009 | WO2009105786A2 Treatment for oral disease |
08/27/2009 | WO2009105759A2 Micro-rnas that modulate smooth muscle proliferation and differentiation and uses thereof |
08/27/2009 | WO2009105739A2 Dna detection by dna chip |
08/27/2009 | WO2009105714A2 Designer oxyphotobacteria and greehouse distillation for photobiological ethanol phoduction from carbon dioxide and water |
08/27/2009 | WO2009105612A2 Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants |
08/27/2009 | WO2009105572A2 Antisense modulation of amyloid beta protein expression |
08/27/2009 | WO2009105551A1 Compositions and methods for amino acid biosynthesis |
08/27/2009 | WO2009105545A1 Methods for screening for agents that affect development |
08/27/2009 | WO2009105492A2 Transgenic plants having altered nitrogen use efficiency characteristics |
08/27/2009 | WO2009105357A1 Vectors and yeast strains for protein production |
08/27/2009 | WO2009105244A1 Recombiant non-human mammalian model for hepatitis infection and immunopathogenesis |
08/27/2009 | WO2009105154A2 Diagnostic and prognostic methods for cancer |
08/27/2009 | WO2009105135A1 Compositions for enhanced uptake of viral vectors in the myocardium |
08/27/2009 | WO2009105084A2 Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
08/27/2009 | WO2009104964A1 Optimisation of expression of parvoviral rep and cap proteins in insect cells |
08/27/2009 | WO2009104958A1 Production of itaconic acid |
08/27/2009 | WO2009104893A2 Root specific expression promoter from capsicum annuum aquaporin gene and uses thereof |
08/27/2009 | WO2009104892A2 High efficiency plant expression promoter from capsicum annuum serine hydroxymethyl transferase gene and uses thereof |
08/27/2009 | WO2009104794A1 Method for producing founder animal for reproducing animals having lethal phenotype caused by gene modification |
08/27/2009 | WO2009104736A1 Antibody having affinity for amyloid plaque in tissue, and pharmaceutical composition comprising the same |
08/27/2009 | WO2009104731A1 L-cysteine-producing bacterium, and method for production of l-cysteine |
08/27/2009 | WO2009104730A1 Identification of hypertension susceptibility gene group |
08/27/2009 | WO2009104698A1 Cholesterol oxidase, chromobacterium sp. microbes, measurement reagent, testing method, gene coding for cholesterol oxidase, recombination vector, transformants, and cholesterol oxidase manufacturing method |
08/27/2009 | WO2009104641A1 Method of detecting and quantifying nematodes in soil and instrument for consolidating soil sample to be used therein |
08/27/2009 | WO2009104622A1 Thermotolerant catalase |
08/27/2009 | WO2009104413A1 Method for screening of anti-cancer agent |
08/27/2009 | WO2009104388A1 Prophylactic/therapeutic agent for collagenosis |
08/27/2009 | WO2009104281A1 Method and gene for imparting or enhancing nonspecific adherence and/or aggregability to microorganism |
08/27/2009 | WO2009104181A1 Plants having genetically modified lignin content and methods of producing same |
08/27/2009 | WO2009104094A2 Method of nucleic acid recombination |
08/27/2009 | WO2009104001A2 Oligopeptidic compounds and uses thereof |
08/27/2009 | WO2009103978A2 Biological materials and uses thereof |
08/27/2009 | WO2009103965A1 Modified linkers |
08/27/2009 | WO2009103960A2 Methods and compositions for modifying plant flavonoid composition and disease resistance |
08/27/2009 | WO2009103898A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases |
08/27/2009 | WO2009103826A1 System for producing multimeric peptides and proteins and use thereof |
08/27/2009 | WO2009103796A1 Use of substances for sensitization of tumor cells to radiation and/or chemotherapy |
08/27/2009 | WO2009103794A1 Hydrazine-modified matrices and use thereof in methods for isolating biomolecules |
08/27/2009 | WO2009103792A1 Novel matrix materials, methods for the production thereof, and use thereof in methods for isolating biomolecules |
08/27/2009 | WO2009103782A1 Means for improving agrobiological traits in a plant by providing a plant cell comprising in its chloroplasts enzymatic activities for converting glycolate into malate |
08/27/2009 | WO2009103752A1 Protein nanocarriers, process for obtaining them and applications |
08/27/2009 | WO2009103547A1 Process for the production of gamma-aminobutyric acid |
08/27/2009 | WO2009103237A1 Method for stonewashing fabrics using cellulase |
08/27/2009 | WO2009103157A1 Mfap4 as a marker for regulatory cells and anti-cancer cells |
08/27/2009 | WO2009103133A1 Genetically modified sequences of trypanosoma cruzi ts and asp-2 antigens, recombinant ts and asp-2 proteins and genetically modified viruses that express the recombinant ts and asp-2 antigens |
08/27/2009 | WO2009103113A1 HUMANIZED ANTI-C5aR ANTIBODIES |
08/27/2009 | WO2009082440A3 Compositions of toll-like receptor agonists and malaria antigens and methods of use |
08/27/2009 | WO2009077479A3 Altering high-density lipoprotein levels through carboxylesterase 1 modulation |
08/27/2009 | WO2009077134A3 Use of rna for reprogramming somatic cells |
08/27/2009 | WO2009076778A8 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
08/27/2009 | WO2009073821A3 Biopolymer-nucleic acid conjugation |
08/27/2009 | WO2009073478A3 Tle3 as a marker for chemotherapy |
08/27/2009 | WO2009071860A3 G immunoglobulin used against anthrax toxins |
08/27/2009 | WO2009066934A3 Methods for improvement of birth rates in canidae on somatic cell nuclear transfer |
08/27/2009 | WO2009064789A3 Methods for detecting and monitoring circulating cancer stem cells |
08/27/2009 | WO2009064416A3 Genetic incorporation of an alpha-hydroxy acid into proteins to generate ester backbone linkages at defined sites |
08/27/2009 | WO2009061379A3 Alpha-amylase variants with altered properties |
08/27/2009 | WO2009055445A3 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
08/27/2009 | WO2009051659A3 Therapeutic sirna molecules for reducing vegfr1 expression in vitro and in vivo |
08/27/2009 | WO2009043922A3 Extracellular targets for alzheimer's disease |
08/27/2009 | WO2009041830A9 Cell-permeabilising peptides and polypeptides for microbial cells |
08/27/2009 | WO2009036067A3 Molecule production by photosynthetic organisms |
08/27/2009 | WO2009020894A3 RNAι-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA |
08/27/2009 | WO2009010974A3 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
08/27/2009 | WO2009009086A3 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut 8) gene expression |
08/27/2009 | WO2008133749A3 Antimicrobial agents from microbial genomes |
08/27/2009 | WO2007092934A8 Methods and compositions for modifying plant biosynthetic pathways |
08/27/2009 | WO2006104035A8 Tripodal functional interface molecule for immobilization of biological molecule and device for detection of gene |
08/27/2009 | WO2006096834A3 Hydrolases, nucleic acids encoding them and methods for improving paper strength |
08/27/2009 | WO2004040000A9 G protein coupled receptors and uses thereof |
08/27/2009 | US20090217424 Constitutive promoters from poplar and uses thereof |
08/27/2009 | US20090217420 Method for transformation using mutant acetolactate synthase gene |
08/27/2009 | US20090217419 Expression cassettes for vascular tissue-preferential expression in plants |
08/27/2009 | US20090217418 Means and methods of controlling plant seed germination |
08/27/2009 | US20090217417 Combination of lipid metabolism proteins and uses thereof |
08/27/2009 | US20090217416 Genetic marker linked to gene locus involved in barley resistance to yellow mosaic disease and use thereof |
08/27/2009 | US20090217415 propagating plants resistant to pigment synthesis-inhibiting class of herbicides; the Nsf1 resistance gene of the present invention encodes a novel gene related to the cytochrome P450 family |
08/27/2009 | US20090217414 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
08/27/2009 | US20090217413 Plant genetic sequences associated with vacuolar ph and uses thereof |
08/27/2009 | US20090217411 Salt responsive genes useful for generating salt resistant transgenic plants |
08/27/2009 | US20090217410 Method of Constructing Transgenic Ice Plant |
08/27/2009 | US20090217409 Methods for increasing the frequency of apomixis expression in angiosperms |
08/27/2009 | US20090217406 Plant cells and plants with increased tolerance to environmental stress |
08/27/2009 | US20090217405 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof |
08/27/2009 | US20090217404 Cell-based RNA interference and related methods and compositions |
08/27/2009 | US20090217402 Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells |
08/27/2009 | US20090217401 Human Monoclonal Antibodies To Programmed Death 1(PD-1) And Methods For Treating Cancer Using Anti-PD-1 Antibodies Alone or in Combination with Other Immunotherapeutics |
08/27/2009 | US20090217399 Lentiviral Vectors That Provide Improved Expression And Reduced Variegation After Transgenesis |
08/27/2009 | US20090217397 Cre-lox based gene knockdown constructs and methods of use thereof |
08/27/2009 | US20090217396 Inflammation models in neurodegenerative and arthritic disorders |
08/27/2009 | US20090217395 Promoter Mutations that Increase Amyloid Precursor Protein Expression |
08/27/2009 | US20090217394 Diabetes Model Animal |
08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
08/27/2009 | US20090217391 T1r3 a novel taste receptor |
08/27/2009 | US20090216458 Biological-Information Processing Apparatus, Biological-Information Processing Method, Biological-Information Processing Program and Program Recording Medium |